Jindal Supreme (India) IPO Day 1: GMP ₹27

Well, the much-anticipated Jindal Supreme (India) IPO has officially opened its subscription window today, September 16, 2026, and as expected for Day 1, it’s a quiet start. With the IPO period running until September 18th, it’s still very early days, and the initial subscription numbers are exactly that: initial. Let’s dive into what we’re seeing on the ground.

Subscription Status

As of the close of Day 1, the subscription figures for Jindal Supreme are showing 0x across all categories – Retail, NII (Non-Institutional Investors), and QIB (Qualified Institutional Buyers). This might raise an eyebrow for some, but it’s not uncommon for mainboard IPOs, especially on the first day. Typically, the bulk of subscription activity happens in the latter half of the IPO period. Retail investors often wait to gauge the sentiment, while NIIs and QIBs might be strategically deploying their capital closer to the closing date. The absence of initial numbers doesn’t necessarily mean a lack of interest; it simply indicates that the market hasn’t fully engaged yet. We’ll need to keep a close watch over the next two days to see how this picture develops. The lot size is 161 shares, and the issue price is set at ₹93.

GMP Update

Now, let’s talk Grey Market Premium (GMP). The current GMP for Jindal Supreme stands firm at ₹27, exactly where it was yesterday. This stability is interesting. While it hasn’t seen an uptick, the fact that it’s holding steady at ₹27 suggests a consistent, albeit moderate, positive sentiment among market participants regarding the potential listing gains. This GMP of ₹27, when added to the issue price of ₹93, points towards an expected listing price of approximately ₹120. A steady GMP, even without an increase, can be encouraging as it avoids the potential red flag of a declining premium. It shows a baseline level of demand that’s being factored in by the grey market.

Should You Apply?

So, the million-dollar question: should you be applying for Jindal Supreme? That’s a decision that needs careful consideration. On one hand, the GMP is positive, suggesting potential listing gains. The expected listing price of ₹120 from the ₹93 issue price is a healthy jump. However, the complete lack of subscription on Day 1 is something to note. This could be a sign of early caution from investors, or simply that the market is waiting for more data. It’s important to remember that GMP is an unofficial indicator and not a guarantee. SEBI advisors often recommend looking at the company’s fundamentals, financial health, and future prospects in addition to market sentiment. Given the current data, it’s a balanced scenario. If you’re a risk-taker looking for potential short-term gains and are comfortable with the current GMP, you might consider applying. However, if you prefer more concrete subscription data and a clearer market signal, it might be prudent to wait and observe the subscription levels on Day 2 and Day 3. Ultimately, your investment decision should align with your risk appetite and investment goals. For a deeper dive into the company’s details, you can View Full Jindal Supreme (India) IPO Details.